Kedudukan dalam Saham
#6891
BELLUS Health Inc. is a biopharmaceutical firm in the clinical development... BELLUS Health Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to creating new therapeutic options for intractable chronic cough (RCC) and various other conditions characterized by heightened cough sensitivity. The company's primary investigational compound, BLU-5937, functions as a P2X3 receptor antagonist. This drug is currently progressing through Phase II clinical trials, where it is being assessed for its potential in treating both RCC and persistent itching. Founded in 1993, BELLUS Health Inc. is headquartered in Laval, Canada.
Harga Saham
$14.30
Disegerakkan terakhir: 2023-06-29
Perubahan (1 hari)
-2.81%
Perubahan (1 tahun)
0.00%
Perdagangan BELLUS Health Inc. (BLU)
Harga BLU dengan permodalan pasaran b
Modal pasaran bagi BELLUS Health Inc.(BLU)
Modal Pasaran: $1.81B
Sehingga August 2026, BELLUS Health Inc. mempunyai modal pasaran sebanyak $1.81B. Ini menjadikan BELLUS Health Inc. syarikat ke-6891st paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran BELLUS Health Inc. dari 2000 hingga 2026
BLU berbanding dengan 5 teratas yang paling popular stocks
| Harga BLU |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.532T
|
+304,999.94%
|
|
|
|
|
$4.608T
|
+254,067.10%
|
|
|
|
|
$4.096T
|
+225,797.86%
|
|
|
|
|
$3.748T
|
+206,647.35%
|
|
|
|
|
$2.761T
|
+152,204.78%
|
